On March 6, the president signed an $8.3 billion funding bill for COVID-19-related activities for the United States and abroad.
DPH reports that the risk of the novel coronavirus – newly named Covid-19 last week by the World Health Organization – is still low in Massachusetts.
Registration is open for MHA’s Annual Design, Operation & Construction Conference.
There is a “voluntary product hold” and pending nationwide recall of surgical gowns distributed by Cardinal Health of Dublin, Ohio.
The Executive Office of Health & Human Services has released proposed regulations that would give MassHealth the authority to designate and exclude from MassHealth coverage high-cost drugs that are purchased under the 340B program.
The Massachusetts Clean Energy Center is offering an "ACTNow” funding opportunity designed to promote clean transportation solutions.
DPH issued a notice to hospitals last week indicating that it is aware of the nationwide shortage of Intravenous Immune Globulin, and urged pharmacy managers to re-familiarize themselves with Guidelines on Managing Drug Product Shortages.
DPH is proposing regulations that will require almost every prescription generated in Massachusetts to be issued in a federally compliant electronic format as opposed to being written on a paper pad.
One item that stood out in the HPC’s meeting last week was the ever-increasing price of insulin.
The 2018 Cost Trends Report from the Health Policy Commission released last month showed the persistent growth in prescription drug spending over the state’s healthcare cost growth benchmark.
The American Hospital Association released a report last week showing that total drug spending per hospital admission increased 18.5% between FYs 2015 and 2017.
Last week, Sen. Bernie Sanders (I-Vermont), along with several Democratic Senate and House members, including House Oversight Committee Chairman Elijah Cummings (D-Md.), announced the release of three bills intended to lower drug prices.
A U.S. District Court has issued a permanent injunction to CMS, halting the federal government’s nearly 30% reduction in reimbursements to certain hospital outpatient departments purchasing drugs through the 340B program.
The American Hospital Association last week announced 340B drug program “good stewardship principles.”
Hospitals are still reporting that they are low on IV bags, saline and emergency products.
There's been a nationwide shortage of IV fluids through injection bags since Hurricane Maria disrupted production facilities in Puerto Rico.